Literature DB >> 28656745

Anxiety affects disability and quality of life in patients with painful diabetic neuropathy.

C C Geelen1,2, R J E M Smeets2,3, S Schmitz2, J P van den Bergh4,5, M E J B Goossens2, J A Verbunt1,2.   

Abstract

BACKGROUND: Painful diabetic neuropathy (PDN) is known to negatively affect psychosocial functioning as expressed by enhanced levels of anxiety and depression. The aim of this study was to specify diabetes and pain-related fears.
METHODS: This questionnaire-based cross-sectional study included 154 patients with PDN (mean age 65.7 ± 6.6 years). Correlation analyses corrected for age, gender, pain intensity, pain duration and insulin treatment were performed to assess the associations of fear of hypoglycaemia (Hypoglycaemia Fear Survey, HFS), kinesiophobia (Tampa Scale of Kinesiophobia, TSK), fear of pain (Pain Anxiety Symptom Scale, PASS-20), fear of falling (Falls Efficacy Scale-I, FES-I), fear of fatigue (Tampa Scale of Fatigue, TSF) and fear of negative evaluation (Brief Fear of Negative Evaluation Scale, BFNE), with quality of life (QoL) (Norfolk Quality of Life Questionnaire, Diabetic Neuropathy Version, QOL-DN) and disability (Pain Disability Index, PDI), respectively.
RESULTS: In univariate analyses, all fears were independently associated with QOL-DN and PDI (p < 0.001 for all variables). Linear regression models including all fears and confounders, showed that pain intensity, pain duration and FES-I were significantly associated with QOL-DN (R2  = 0.603). Pain intensity, male gender and FES-I were significantly associated with PDI (R2  = 0.526).
CONCLUSIONS: After controlling for confounders, levels of pain intensity, duration of pain and fear of falling were negatively associated with QoL in patients with PDN. Pain intensity, male gender and fear of falling were positively associated with disability. Specifying fears enables us to identify potential targets for behavioural interventions that aim to improve psychosocial well-being in patients with PDN. SIGNIFICANCE: This study shows that patients with PDN suffer from various fears, which should enable us to design a treatment strategy that directly targets these fears, hereby improving physical and psychosocial well-being in these patients.
© 2017 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2017        PMID: 28656745     DOI: 10.1002/ejp.1067

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  7 in total

1.  A qualitative study of the experience and impact of neuropathic pain in people living with HIV.

Authors:  Whitney Scott; Maite Garcia Calderon Mendoza Del Solar; Harriet Kemp; Lance M McCracken; Amanda C de C Williams; Andrew S C Rice
Journal:  Pain       Date:  2020-05       Impact factor: 7.926

2.  Quality of Life in Painful Peripheral Neuropathies: A Systematic Review.

Authors:  Ayesha Girach; Thomas Henry Julian; Giustino Varrassi; Antonella Paladini; Athina Vadalouka; Panagiotis Zis
Journal:  Pain Res Manag       Date:  2019-05-23       Impact factor: 3.037

Review 3.  Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts.

Authors:  Fahmy Amara; Sherif Hafez; Abbas Orabi; Adel El Etriby; Aly Ahmed Abdel Rahim; Ebtissam Zakaria; Farouk Koura; Farouk Mohamed Talaat; Hanan Gawish; Ihab Attia; Mohamed Fahmy Abdel Aziz; Mohamed Hesham Mohamed Fahmy El Hefnawy; Mohamed Kamar; Mohamed Reda Halawa; Mohamed Shawky El-Sayed; Nabil Abdelfatah El Kafrawy; Samir Helmy Assaad Khalil; Samir Naem Assaad
Journal:  Curr Diabetes Rev       Date:  2019

4.  Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes.

Authors:  Sandra Sif Gylfadottir; Diana Hedevang Christensen; Sia Kromann Nicolaisen; Henning Andersen; Brian Christopher Callaghan; Mustapha Itani; Karolina Snopek Khan; Alexander Gramm Kristensen; Jens Steen Nielsen; Søren Hein Sindrup; Niels Trolle Andersen; Troels Staehelin Jensen; Reimar Wernich Thomsen; Nanna Brix Finnerup
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

5.  Effectiveness of Exposure in Vivo for Patients with Painful Diabetic Neuropathy: a Pilot Study of Effects on Physical Activity and Quality of Life.

Authors:  Charlotte C M van Laake-Geelen; Rob J E M Smeets; Marielle E J B Goossens; Jeanine A Verbunt
Journal:  J Rehabil Med Clin Commun       Date:  2021-02-10

6.  Biopsychosocial Rehabilitation Treatment "Exposure In Vivo" for Patients with Painful Diabetic Neuropathy: Development of a Treatment Protocol.

Authors:  Charlotte C M Van Laake-Geelen; Rob J E M Smeets; Thijs Van Meulenbroek; Marlies Den Hollander; Marielle E J B Goossens; Jeanine A Verbunt
Journal:  J Rehabil Med Clin Commun       Date:  2019-06-15

7.  Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients.

Authors:  Mohammadreza Davoudi; Parnian Rezaei; Fereshteh Rajaeiramsheh; Seyed Majid Ahmadi; Amir Abbas Taheri
Journal:  Health Qual Life Outcomes       Date:  2021-02-09       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.